For investors and angels
The most repeated act of care in 15,000 facilities, measured. Quality of care controlled and assured, reducing risk and leakage with high ROI potential.
Guardian Agents makes operational protocols verifiable, quality-controlled and easy to manage. Facilities pay about $20 per bed per month against roughly $3,000 per bed per year in leakage. And they fill beds they cannot staff today, with a protocol that holds through 70% turnover.
An easy-to-pair sensor and a SaaS platform that feeds the EHR through an official marketplace integration. Recurring per-bed revenue, an 80%+ gross margin target and early profitability. Turning is the first protocol at about $20 per bed per month; mobility protocols follow and can double revenue per bed and the serviceable market.
What this means for you
A painful, expensive problem
Turning failures drive pressure injuries, clawbacks, rehospitalization penalties, federal fines, lawsuits and insurance premium hikes. The leakage is real and it recurs every year.
Unlocks capacity
Facilities that keep beds empty for lack of staff can fill them, with a protocol that holds when most of the floor changes every year. A second ROI on top of the leakage.
Minimal time to value
Pilots roll out fast with minimal friction: existing Wi-Fi, a sensor and a phone. No infrastructure to install.
A platform, not a point product
Turning first. Mobility and more protocols next, multiplying revenue per bed and the serviceable market.
Why facilities buy, and why nurses want it.
The administrator carries the survey, readmission, insurance and litigation exposure, and today has no real oversight of the protocols behind it. Guardian Agents gives them proof of care and a DON who sees every deviation as it happens.
Nurses want it because it takes work off them: turns are logged automatically, and the DON reviews exceptions instead of chasing charts. Adoption needs no capital project: existing Wi-Fi, a sensor and a phone.
Margins are thin in skilled nursing, which is the point: the price is set against the exposure, not against the software budget. One $240,000 verdict equals about ten years of the system for a 100-bed facility.
Over $1B a year on the first protocol alone.
Serviceable market at $20 per bed per month for Phase 1, the turning protocol. Phase 2 adds mobility protocols, driven by market feedback, and can double revenue per bed and the serviceable market.
2026 market sizes for Phase 1. Every added protocol multiplies them.
Customer economics: 12.5× ROI potential.
Why a facility pays: a small monthly cost against a much larger, recurring leakage.
Plus capacity: beds that sit empty for lack of staff get filled, revenue the leakage figure does not even count. And the ceiling is high: a Florida nuclear verdict passed $1 billion in 2013.
Margins and profitability.
Recurring SaaS at about $20 per bed per month, all in. Gross margin target above 80%, about 85% in the plan. We plan to be profitable in year two.
Why this wedge, and why nothing else does it.
At-risk residents are repositioned around the clock on individualized schedules: the most repeated act of care in the building. Adherence decides whether a facility can prove its pressure-injury protocol was followed, and today it is verified by a note in the chart.
| Approach | What it gives | Bottom line |
|---|---|---|
| Manual charting (paper or EHR) | A note written after the turn | Slow, error-prone, and it rarely holds up in a clawback review or a hearing |
| Medical-device wearables (e.g. S+N Leaf, BioSensics) | Logs and recommends positioning | Expensive sensors, dedicated infrastructure, installation projects |
| Pressure mats and smart beds (e.g. Earlysense, Stryker) | Bed-level signals | No record of the turn or the position |
| Guardian Agents | Easy-to-pair sensor. Transparent, frictionless SaaS platform integrated directly with the EHR, feeding the data straight into it | Low cost. Existing Wi-Fi. Automatic recording. Straight into the EHR. |
Land and expand.
- California, Florida and New York, the high-litigation states
- USA
- Europe
- Rest of the world
- US (Delaware) incorporation for tax benefits and QSBS; a low-cost R&D hub in the Americas under Israeli engineering leadership.
- Upsell more protocols and insights: mobility protocols, advanced analytics, operational optimization and anomaly detection.
- Cross over to adjacent markets: assisted living, aging in place, infant care and disability care.
- The medical track (FDA 510(k)) later, building on market presence and the data flywheel.
Data flywheel.
Every deployment adds to a long-term record of real-world movement and care events. That record is the asset: it powers the next protocols, the next products and the medical track.
The round, and who we are looking for.
We are raising around $1M to kickstart everything, including our proprietary Gen-1 sensor.
We are looking for (1) leaders from the SNF, post-acute and long-term care market: CEOs, COOs, risk and legal; (2) market influencers, evangelists and door openers; (3) angels, accelerators and investment funds. Preferably a combination of all three.
Open the investor briefQuestions investors ask
What does the system cost a facility?
About $20 per bed per month, very little against the exposure it addresses. For the facility it is designed to pay for itself many times over: one serious pressure-injury verdict, around $240,000, equals the system's cost for a 100-bed building for about ten years, and the leakage per bed is more than twelve times the yearly cost. That is the buying logic: a small recurring line under a large, recurring exposure.
Skilled nursing runs on thin margins. Will operators really pay?
Yes. The buyer is the administrator, who already carries the survey, readmission, insurance and litigation exposure. At $20 per bed per month against roughly $3,000 of leakage per bed per year, plus beds they can now staff, the ROI potential is clear in their own numbers.
Why won't an EHR vendor or an incumbent just build this?
EHR vendors sell charting to 15,000 facilities. Sensors, pairing and signal processing are a different business, and the marketplace integration makes Guardian Agents their partner, not their rival. An EHR stores what was charted; it does not measure the turn. Medical-grade positioning wearables need expensive sensors, infrastructure and installation, and pressure mats and smart beds give bed-level signals without real pose or turning data.
What are the margins?
Software margins. The sensor is small and reusable, and the revenue is recurring per-bed SaaS: an 80%+ gross margin target, about 85% in the plan.
Does it need FDA clearance?
No. Phase 1 is operational proof of a care protocol: no diagnosis, no clinical decision support, no treatment guidance. The medical track (FDA 510(k)) is upside we take later, as its own step.
How long is the sales cycle?
Short. The pain is real and felt every month, installation is quick and frictionless, and time to value is very short: existing Wi-Fi, a sensor and a phone. The cycle depends mostly on each facility's IT team enabling the Guardian Agents VPN connection.
Why now?
Verdicts keep rising, insurers are raising premiums or leaving the market, 70% turnover leaves nurses with the oversight burden and empty beds, and the Silver Tsunami adds residents every year. Facilities need care they can prove, at a cost their margins allow.
What is the data worth?
Every deployment builds a governed, longitudinal record of real-world movement and care events. It powers the next protocols first, then upsells, adjacent markets and the option to go medical.
What does this round fund?
Around $1M kickstarts everything: our proprietary Gen-1 sensor, the platform and the first design-partner deployments, and carries us to profitability in year two.
Founder conversations
Back the company that makes care provable.
Talk with Yogev, our founder, about the scaling and growth potential, high profit margins and early profitability.
Schedule a meeting with Yogev. Pick any open time.
or email yogev@guardian-agents-us.com